canvac 4+bb combination vaccine pack
zoetis australia pty ltd - bordetella bronchiseptica (inactivated cell free extract; canine adeno virus type 2; canine distemper virus - living; canine parainfluenza virus; canine parvo virus type 2; thiomersal - parenteral liquid/solution/suspension - bordetella bronchiseptica (inactivated cell free extract vaccine-microbial active 0.0 p; canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus - living vaccine-viral active 0.0 p; canine parainfluenza virus vaccine-viral active 0.0 p; canine parvo virus type 2 vaccine-viral active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - dog | bitch | castrate | puppy - bordetella bronchiseptica | canine distemper | canine parainfluenza | canine parvovirus | hepatitis :- infectious | canine adenovirus type 1 | canine adenovirus type 2 | canine cough syndrome | infectious canine hepatitis | infectious tracheobronchitis | parvovirus
ultravac scourshield vaccine
zoetis australia pty ltd - bovine rotavirus g10; bovine rotavirus g6; e. coli strain - o64:k99; bovine coronavirus (inactivated); gentamicin; formaldehyde; thiomersal - misc. vaccines or anti sera - bovine rotavirus g10 active 1.0 rp/2ml d; bovine rotavirus g6 active 1.3 rp/2ml d; e. coli strain - o64:k99 vaccine-microbial active 1.0 rp/2ml d; bovine coronavirus (inactivated) vaccine-viral active 1.0 rp/2ml d; gentamicin antibiotic other 30.0 ug/ml; formaldehyde aldehyde other 0.74 mg/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - cow - pregnant | healthy pregnant heifer | bovine | pregnant cow - neonatal calf diarrhea
fevac f5 vaccine
zoetis australia pty ltd - feline calicivirus - inactivated; feline leukaemia virus - inactivated; feline chlamydia psittaci - inactivated; feline panleucopenia virus - inactivated; feline rhinotracheitis virus - inactivated - misc. vaccines or anti sera - feline calicivirus - inactivated vaccine-viral active 0.0 u; feline leukaemia virus - inactivated vaccine-viral active 0.0 u; feline chlamydia psittaci - inactivated vaccine-viral active 0.0 u; feline panleucopenia virus - inactivated vaccine-viral active 0.0 u; feline rhinotracheitis virus - inactivated vaccine-viral active 0.0 u - immunotherapy - cat - over 8 weeks of age - feline calicivirus | feline chlamydia psittaci | feline enteritis | feline leukaemia virus | feline rhinotracheitis | calicivirus (feline) | disease caused by | enteritis (feline) | fcv | feline herpesvirus type 1 | feline infectious enteritis | feline panleucopenia (fp) | fhv-1 | fvr | herpesvirus 1 (feline) | herpesvirus type 1 (feline) | panleucopenia (feline) | rhinotracheitis (feline)
fevac f4 vaccine
zoetis australia pty ltd - feline calicivirus - inactivated; feline chlamydia psittaci - inactivated; feline panleucopenia virus - inactivated; feline rhinotracheitis virus - inactivated - misc. vaccines or anti sera - feline calicivirus - inactivated vaccine-viral active 0.0 u; feline chlamydia psittaci - inactivated vaccine-viral active 0.0 u; feline panleucopenia virus - inactivated vaccine-viral active 0.0 u; feline rhinotracheitis virus - inactivated vaccine-viral active 0.0 u - immunotherapy - cat - over 8 weeks of age - feline calicivirus | feline chlamydia psittaci | feline enteritis | feline rhinotracheitis | calicivirus (feline) | enteritis (feline) | fcv | feline herpesvirus type 1 | feline infectious enteritis | feline panleucopenia (fp) | fhv-1 | fvr | herpesvirus 1 (feline) | herpesvirus type 1 (feline) | panleucopenia (feline) | rhinotracheitis (feline)
fevac 3 vaccine
zoetis australia pty ltd - feline calicivirus - inactivated; feline panleucopenia virus - inactivated; feline rhinotracheitis virus - inactivated; thiomersal - parenteral liquid/solution/suspension - feline calicivirus - inactivated vaccine-viral active 0.0 p; feline panleucopenia virus - inactivated vaccine-viral active 0.0 p; feline rhinotracheitis virus - inactivated vaccine-viral active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - cat | cat - queen | cat - tom | kitten - feline calicivirus | feline enteritis | feline rhinotracheitis | calicivirus (feline) | enteritis (feline) | fcv | feline herpesvirus type 1 | feline infectious enteritis | feline panleucopenia (fp) | fhv-1 | fvr | herpesvirus 1 (feline) | herpesvirus type 1 (feline) | panleucopenia (feline) | rhinotracheitis (feline)
poulvac laryngo sa2
zoetis australia pty ltd - infectious laryngotracheitis virus strain s.a.2; gentamicin; nystatin - misc. vaccines or anti sera - infectious laryngotracheitis virus strain s.a.2 vaccine-viral active 0.0 p; gentamicin antibiotic other 0.44 ug/do; nystatin antibiotic other 0.44 units/do - immunotherapy - poultry | breeders | broiler | chickens | chicks | chooks | day old chicks | hatchlings | layers - infectious laryngotracheitis | gallid herpesvirus 1 | ilt
rotateq
merck sharp & dohme b.v. - rotavirus serotype g1, serotype g2, serotype g3, serotype g4, serotype p1 - immunization; rotavirus infections - vaccines, viral vaccines - rotateq is indicated for the active immunisation of infants from the age of six weeks to 32 weeks for prevention of gastroenteritis due to rotavirus infection.rotateq is to be used on the basis of official recommendations.
vaxipet dhppi+l freeze dried lyophilised vaccine virus febris contagiosae canis min. 103.0, max. 104.5 tcid50 virus laryngotracheitidis contagiosae canis min. 103.5, max. 104.5 tcid50 parvovirus enteritidis canis min 104.5, max. 105.5 tcid50 virus parainfluensis canis min 103.0, max. 104.2 tcid50 leptos
laprovet, france - virus febris contagiosae canis min. 103.0tcid50, max. 104.5tcid50 , virus laryngotracheitidis contagiosae canis min. 103.5tcid50, max. 104.5tcid50 , - freeze dried lyophilised vaccine - virus febris contagiosae canis min. 103.0, max. 104.5 tcid50 virus laryngotracheitidis contagiosae canis min. 103.5, max. 104.5 tcid50 parvovirus enteritidis canis min 104.5, max. 105.5 tcid50 virus parainfluensis canis min 103.0, max. 104.2 tcid50 leptos
vaxipet dhppi+lr freeze dried lyophilised vaccine virus febris contagiosae canis min. 103.0, max. 104.5 tcid50 virus laryngotracheitidis contagiosae canis min. 103.5, max. 104.5 tcid50 parvovirus enteritidis canis min. 104.5, max. 105.5 tcid50 virus parainfluensis canis min. 103.0, max. 104.2 tcid50 lept
laprovet, france - virus febris contagiosae canis min. 103.0tcid50, max. 104.5tcid50 , virus laryngotracheitidis contagiosae canis min. 103.5tcid50, max. 104.5tcid50 , - freeze dried lyophilised vaccine - virus febris contagiosae canis min. 103.0, max. 104.5 tcid50 virus laryngotracheitidis contagiosae canis min. 103.5, max. 104.5 tcid50 parvovirus enteritidis canis min. 104.5, max. 105.5 tcid50 virus parainfluensis canis min. 103.0, max. 104.2 tcid50 lept
protech c3 + 2i
boehringer ingelheim animal health australia pty. ltd. - leptospirosis - dog - leptospira icterohaemorrhagiae; canine adeno virus type 2; canine coronavirus vaccine - antigen; canine distemper virus strain onderstepoort; canine parvo virus - misc. vaccines or anti sera - leptospirosis - dog - leptospira icterohaemorrhagiae vaccine active 0.0 u; canine adeno virus type 2 vaccine-viral active 0.0 u; canine coronavirus vaccine - antigen vaccine-viral active 0.0 u; canine distemper virus strain onderstepoort vaccine-viral active 0.0 u; canine parvo virus vaccine-viral active 0.0 u - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine coronavirus | canine distemper | canine parvovirus | leptospira icterohaemorrhagiae | parvovirus